Iterum Therapeutics PLC
NASDAQ:ITRM
Iterum Therapeutics PLC
NASDAQ:ITRM
Price:
1.5 USD
16.28%
Market Closed
Updated:
Jun 3, 2024
Iterum Therapeutics PLC
Net Change in Cash
|
Iterum Therapeutics PLC
Net Change in Cash Peer Comparison
Comparables:
PRGO
JAZZ
AVDL
G
GHRS
COPN
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Iterum Therapeutics PLC
NASDAQ:ITRM
|
Net Change in Cash
-$9.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Perrigo Company PLC
NYSE:PRGO
|
Net Change in Cash
$105.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-10%
|
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Net Change in Cash
$624.8m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Net Change in Cash
-$47.6m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Net Change in Cash
-$87.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Net Change in Cash
-€135.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Iterum Therapeutics PLC's Net Change in Cash?
Net Change in Cash
-9.5m
USD
-9.5m
USD
Based on the financial report for Mar 31, 2024, Iterum Therapeutics PLC's Net Change in Cash amounts to -9.5m USD.
What is Iterum Therapeutics PLC's Net Change in Cash growth rate?
Net Change in Cash CAGR 1Y
35%
35%
Over the last year, the Net Change in Cash growth was 35%.
You don't have any saved screeners yet
